Organization Profile

You just read:

Oncolytics Biotech® Inc. Completes Patient Enrollment in U.S. Phase I Clinical Trial Investigating REOLYSIN® in Combination with FOLFIRI in Patients with Colorectal Cancer

News provided by

Oncolytics Biotech Inc.

Aug 16, 2012, 07:00 ET